See more : Konoshima Chemical Co.,Ltd. (4026.T) Income Statement Analysis – Financial Results
Complete financial analysis of Chemfab Alkalis Limited (CHEMFABALKA.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chemfab Alkalis Limited, a leading company in the industry within the sector.
- Nykredit Invest Danske Aktier Akk KL (NYIDAA.CO) Income Statement Analysis – Financial Results
- Oasis Petroleum Inc. (OAS) Income Statement Analysis – Financial Results
- Ifuji Sangyo Co., Ltd. (2924.T) Income Statement Analysis – Financial Results
- Revolution Medicines, Inc. Warrant (RVMDW) Income Statement Analysis – Financial Results
- Hammond Power Solutions Inc. (HMDPF) Income Statement Analysis – Financial Results
Chemfab Alkalis Limited (CHEMFABALKA.BO)
Industry: Chemicals
Sector: Basic Materials
About Chemfab Alkalis Limited
Chemfab Alkalis Limited manufactures and sells inorganic chemicals in India and internationally. The company operates through Chemicals and Related Products/Services; and PVC-O Pipes segments. It offers caustic soda lye and flakes, liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite/bleach liquor products, as well as industrial grade and edible salt products. The company was formerly known as Teamec Chlorates Limited and changed its name to Chemfab Alkalis Limited in July 2017. Chemfab Alkalis Limited was founded in 1985 and is based in Chennai, India.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 3.31B | 2.72B | 1.81B | 2.05B | 1.93B |
| Cost of Revenue | 2.19B | 2.19B | 1.61B | 1.58B | 1.32B |
| Gross Profit | 1.12B | 523.17M | 198.73M | 467.95M | 612.09M |
| Gross Profit Ratio | 33.90% | 19.26% | 10.99% | 22.88% | 31.66% |
| Research & Development | 6.14M | 3.74M | 5.46M | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 214.90M | 145.96M | 95.04M | 144.00M | 138.61M |
| Other Expenses | -17.16M | -8.44M | -3.49M | -6.64M | -3.02M |
| Operating Expenses | 238.20M | 158.13M | 104.00M | 150.64M | 141.63M |
| Cost & Expenses | 2.43B | 2.35B | 1.71B | 1.73B | 1.46B |
| Interest Income | 5.95M | 5.34M | 2.27M | 17.71M | 26.48M |
| Interest Expense | 5.18M | 11.22M | 27.70M | 35.51M | 24.60M |
| Depreciation & Amortization | -229.31M | -222.21M | -202.20M | -250.88M | -149.21M |
| EBITDA | 1.11B | 587.25M | 296.94M | 568.19M | 619.68M |
| EBITDA Ratio | 33.63% | 21.62% | 16.42% | 27.78% | 32.06% |
| Operating Income | 885.04M | 365.04M | 94.73M | 317.32M | 470.46M |
| Operating Income Ratio | 26.71% | 13.44% | 5.24% | 15.51% | 24.34% |
| Total Other Income/Expenses | 9.34M | 25.98M | -74.48M | -48.76M | -185.63M |
| Income Before Tax | 894.39M | 391.02M | 20.26M | 268.55M | 284.84M |
| Income Before Tax Ratio | 26.99% | 14.40% | 1.12% | 13.13% | 14.74% |
| Income Tax Expense | 248.55M | 103.55M | 101.57M | 12.66M | 117.28M |
| Net Income | 645.83M | 287.47M | -81.32M | 255.89M | 167.56M |
| Net Income Ratio | 19.49% | 10.58% | -4.50% | 12.51% | 8.67% |
| EPS | 45.14 | 20.20 | -5.77 | 18.27 | 11.96 |
| EPS Diluted | 45.14 | 20.20 | -5.77 | 18.27 | 11.96 |
| Weighted Avg Shares Out | 14.16M | 14.12M | 14.01M | 13.93M | 13.88M |
| Weighted Avg Shares Out (Dil) | 14.31M | 14.23M | 14.10M | 14.01M | 14.01M |
Source: https://incomestatements.info
Category: Stock Reports